Worldwide Webinar Series:

Impact of Modeling & Simulation in Drug Development

Rosa’s Worldwide Webinar Series fosters the adoption of modeling and simulation by informing a broad audience about the strategic impact it can have on all aspects of research and development.

Since its inception in 2011, this complimentary monthly series has featured select speakers from academia, industry, Rosa client companies, and Rosa itself. The series has drawn many thousands of attendees worldwide from all drug development disciplines.

PLEASE NOTE - ***ALL WEBINARS PRIOR to 2017*** are available by contacting us CLICK HERE 

Sign up to receive Webinar and QSP News Alerts

Subscribe
Date Presenter / Topic Register

Robin T.U. Haid, Ph.D.
Last year, Robin Haid received his PhD from ETH Zurich's department of Chemistry and Applied Biosciences for his thesis on the PK/PD Modeling of Targeted Protein Degraders, which he had carried out in collaboration with Bayer in Berlin. Having joined that company as a Senior Scientist, he then went on a secondment with Vividion, a subsidiary biotech firm located in San Diego, CA. Robin has served as the modeling representative on several degrader programs, covering all phases of drug discovery and development from lead identification up to first-in-human trials. In his scientific endeavors, Robin strives to fuse mathematical rigor with the outcome-oriented mindset that drives project success, and he does so in an engaging and accessible manner. Thus, it is no wonder that colleagues in the field have adopted many of the memorable and highly expressive figures and case studies from his research articles and scientific talks for their own educational material. Outside of work, Robin enjoys the newfound freedom of post-student life and all that California has to offer, be it snorkeling with dolphins or trail running among rattle snakes.

Hang on Tight: Scaling New Heights in Covalent Degrader Discovery through PK/PD Modeling
More Info